Initial Workup and Management for Multiple Hematomas
The initial workup for a patient with multiple hematomas should include rapid assessment of hemodynamic status, identification of bleeding sources through imaging, and aggressive resuscitation with blood products while maintaining fibrinogen levels above 1.5 g/L and platelet count above 75 × 10⁹/L. 1, 2
Immediate Assessment
Hemodynamic evaluation:
Laboratory investigations:
Imaging
For hemodynamically unstable patients:
For hemodynamically stable patients:
Resuscitation Strategy
Blood product administration:
- Follow availability order: O-negative, group-specific, cross-matched blood 1, 2
- Implement high-ratio transfusion strategy (at least 1 unit plasma per 2 units RBC) 2
- Target fibrinogen levels >1.5 g/L using cryoprecipitate or fibrinogen concentrate 1, 2
- Maintain platelet count >75 × 10⁹/L 1, 2
- Actively warm patient and all transfused fluids 1
Volume replacement:
Management Based on Hematoma Location and Severity
For hemodynamically stable hematomas:
For expanding or hemodynamically significant hematomas:
For patients on anticoagulants:
Ongoing Management
Monitoring:
Coagulopathy management:
Post-bleeding care:
Common Pitfalls and Caveats
Don't underestimate blood loss - patients may compensate well despite significant hemorrhage 1
Don't delay resuscitation while waiting for diagnostic procedures 2
Don't rely on single hematocrit measurements as isolated markers for bleeding 1
Avoid vasopressors if possible as they may worsen bleeding 1
Don't forget about consumptive coagulopathy - particularly in obstetric hemorrhage, trauma with head injury, and sepsis 1
Don't overlook anticoagulant medications - patients on anticoagulants have greater risk of coagulopathic bleeding 1
Establish clear communication - appoint a team leader to coordinate care 2
By following this structured approach to the workup and management of multiple hematomas, clinicians can effectively identify the source of bleeding, implement appropriate resuscitation measures, and minimize morbidity and mortality associated with significant blood loss.